Table 2 Results – base case analysis and scenario analysis
From: Screen or not to screen for peripheral arterial disease: guidance from a decision model
PROBABILISTIC RESULTS (discounted) | ||||||||
|---|---|---|---|---|---|---|---|---|
Diagnostic test | Treatment | Costs | LYs | QALYs | iCosts | iLY | iQALYs | iCERs |
Base case | Â | Â | Â | Â | Â | Â | Â | Â |
No screen | Low dose aspirin | 28052 | 20.69 | 15.58 | Â | Â | Â | Â |
ABI screening | Low dose aspirin | 26548 | 21.79 | 15.66 | -1503 | 1.10 | 0.007 | Dominant |
Scenario analysis with Clopidogrel | ||||||||
No screen | Clopidogrel | 29464 | 22.33 | 15.95 | Â | Â | Â | Â |
ABI | Clopidogrel | 27681 | 22.57 | 16.17 | -1783 | 0.24 | 0.22 | Dominant |
PROBABILISTIC RESULTS (undiscounted) | ||||||||
Diagnostic test | Treatment | Costs | LYs | QALYs | iCosts | iLY | iQALYs | Â |
Base case | ||||||||
No screen | Low dose aspirin | 63155 | 26.32 | 19.40 | Â | Â | Â | Â |
ABI screening | Low dose aspirin | 59544 | 27.47 | 19.50 | -3611 | 1.15 | 0.11 | Â |
Scenario analysis with Clopidogrel | ||||||||
No screen | Clopidogrel | 67799 | 28.30 | 19.96 | Â | Â | Â | Â |
ABI | Clopidogrel | 63759 | 28.66 | 20.27 | -4039 | 0.36 | 0.31 | Â |